These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11222431)

  • 1. The failings of NICE. NICE's guidance suggests using rosiglitazone in type 2 diabetes later than is ideal.
    Robinson S; Valabhji J; Schachter M
    BMJ; 2001 Feb; 322(7284):491. PubMed ID: 11222431
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thiazolidindiones in type II diabetes mellitus].
    Bornkessel B
    Med Monatsschr Pharm; 1998 Mar; 21(3):66-8. PubMed ID: 9556974
    [No Abstract]   [Full Text] [Related]  

  • 3. Rosiglitazone and type 2 diabetes mellitus.
    Bragg T
    Lancet; 2001 May; 357(9266):1451. PubMed ID: 11360960
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidance on rosiglitazone for type 2 diabetes mellitus.
    Matthews DR
    Lancet; 2001 Feb; 357(9254):481. PubMed ID: 11273100
    [No Abstract]   [Full Text] [Related]  

  • 5. Troglitazone: a new drug for type 2 diabetes mellitus.
    Deb P; Bhatia E
    Natl Med J India; 1998; 11(2):81-2. PubMed ID: 9624868
    [No Abstract]   [Full Text] [Related]  

  • 6. NICE issues guidance on diabetes treatments.
    Iles A
    BMJ; 2003 Sep; 327(7414):520. PubMed ID: 12958096
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tackling insulin resistance. Control of etiology in type 2 diabetes].
    MMW Fortschr Med; 2000 May; 142(21):66-7. PubMed ID: 10872300
    [No Abstract]   [Full Text] [Related]  

  • 8. Rosiglitazone reduces urinary albumin excretion in type II diabetes.
    Bakris G; Viberti G; Weston WM; Heise M; Porter LE; Freed MI
    J Hum Hypertens; 2003 Jan; 17(1):7-12. PubMed ID: 12571611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glitazones--a new therapeutic principle in diabetes].
    Birkeland KI
    Tidsskr Nor Laegeforen; 2001 Sep; 121(22):2617-9. PubMed ID: 11668762
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thiazolidinediones--new antidiabetic agents. Why don't we know how to use them?].
    Gale EA
    Ugeskr Laeger; 2001 Dec; 163(50):7032-5. PubMed ID: 11794032
    [No Abstract]   [Full Text] [Related]  

  • 11. [30-year-old diabetic patients mostly have type 2 diabetes. "Mature" diabetics are becoming increasingly younger].
    MMW Fortschr Med; 2001 Jan; 143(4):46. PubMed ID: 11219286
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination agents for diabetes.
    Samuel J; Rochester CD
    Adv Nurse Pract; 2003 Jun; 11(6):22-4. PubMed ID: 12807051
    [No Abstract]   [Full Text] [Related]  

  • 13. Troglitazone.
    Santiago JV
    Compr Ther; 1997 Aug; 23(8):560-2. PubMed ID: 9283746
    [No Abstract]   [Full Text] [Related]  

  • 14. Rosiglitazone reduces blood pressure and urinary albumin excretion in type 2 diabetes: G Bakris et al.
    Grossman E
    J Hum Hypertens; 2003 Jan; 17(1):5-6. PubMed ID: 12571610
    [No Abstract]   [Full Text] [Related]  

  • 15. [Early effect of therapy with pioglitazone. Vascular damage significantly reduced].
    MMW Fortschr Med; 2002 May; 144(21):53. PubMed ID: 12134428
    [No Abstract]   [Full Text] [Related]  

  • 16. Rosiglitazone maleate. Ketotifen fumarate.
    Am J Health Syst Pharm; 1999 Oct; 56(19):1924-6. PubMed ID: 10554908
    [No Abstract]   [Full Text] [Related]  

  • 17. Are thiazolidinediones first-line agents?
    Weldy DL
    J Fam Pract; 2002 Nov; 51(11):984; author reply 984. PubMed ID: 12485560
    [No Abstract]   [Full Text] [Related]  

  • 18. Conference urges further consultation on NICE diabetes guidance.
    Hawkes N
    BMJ; 2015 Jun; 350():h3203. PubMed ID: 26068012
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of arteriosclerosis with the insulin sensitizer pioglitazone. Early intervention in diabetic patients compensates "cell ignorance"].
    MMW Fortschr Med; 2002 May; 144(21):52-3. PubMed ID: 12134427
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alpha-glucosidase inhibitor and insulin sensitizer combination therapy in NIDDM].
    Kitaoka H
    Nihon Rinsho; 1997 Nov; 55 Suppl():192-6. PubMed ID: 9434466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.